Remove 2024 Remove Radiopharmaceuticals Remove Radiosensitivity
article thumbnail

Blue Earth Therapeutics Announces Promising Results from Preclinical Evaluation of Synergistic Drug Combinations with Radiopharmaceutical 177Lu-rhPSMA-10.1 for Treatment of Prostate Cancer

Imaging Technology

The data were presented in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, Calif. drug combinations with the scientific community at the prestigious AACR Annual Meeting 2024,” said David E. Blue Earth Group, Oxford, UK, at the AACR Annual Meeting 2024 on April 7, 2024.